Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Standardized Insect Venom Allergenic Extract [EPC]
Copaifera Officinalis Resin is a standardized botanical extract classified as an allergenic extract. It is primarily utilized in specialized clinical settings for immunomodomodulation and diagnostic purposes related to hypersensitivity management.
Name
Copaifera Officinalis Resin
Raw Name
COPAIFERA OFFICINALIS RESIN
Category
Standardized Insect Venom Allergenic Extract [EPC]
Drug Count
3
Variant Count
10
Last Verified
February 17, 2026
About Copaifera Officinalis Resin
Copaifera Officinalis Resin is a standardized botanical extract classified as an allergenic extract. It is primarily utilized in specialized clinical settings for immunomodomodulation and diagnostic purposes related to hypersensitivity management.
Detailed information about Copaifera Officinalis Resin
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Copaifera Officinalis Resin.
Copaifera Officinalis Resin, commonly known in botanical circles as Copaiba balsam, is a complex oleoresin obtained from the trunk of the Copaifera officinalis tree, a member of the Fabaceae family native to the Amazon rainforest. In the contemporary pharmacological landscape of 2026, this substance is classified under the Primary Class of Standardized Insect Venom Allergenic Extract [EPC]. This classification reflects its specialized use in the field of allergy and immunology, where standardized extracts are employed for the diagnosis and treatment of hypersensitivity reactions. While traditionally recognized for its anti-inflammatory and antimicrobial properties in South American ethnomedicine, its inclusion in the Established Pharmacologic Class (EPC) for allergenic extracts signifies its role in modern immunotherapy protocols.
The resin is not a single chemical entity but a sophisticated mixture of diterpenes and sesquiterpenes. Historically, the FDA and other global regulatory bodies have monitored the use of botanical resins closely. As a standardized extract, Copaifera Officinalis Resin undergoes rigorous purification to ensure consistent levels of active volatile oils, particularly beta-caryophyllene. This standardization is critical for clinical safety, especially when used in patients with heightened immune sensitivity. Healthcare providers typically utilize this resin in controlled environments to manage specific immune responses or as a component in complex allergenic formulations.
The mechanism of action for Copaifera Officinalis Resin is multifaceted, involving both direct biochemical pathways and indirect immunomodulatory effects. At the molecular level, the primary constituent, beta-caryophyllene (BCP), acts as a selective agonist for the Cannabinoid Receptor Type 2 (CB2). Unlike CB1 receptors, which are primarily located in the central nervous system and mediate psychoactive effects, CB2 receptors are densely populated on immune cells, including microglia, T-cells, and B-cells. By binding to these receptors, the resin components help modulate the release of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukins (IL-1β, IL-6).
In the context of its classification as an allergenic extract, the resin works by inducing a state of desensitization or immune tolerance. When administered in micro-dosages under a standardized protocol, it interacts with the patient's dendritic cells and T-regulatory cells. This interaction shifts the immune response from a Th2-dominant profile (associated with allergic reactions and IgE production) toward a Th1-dominant or T-reg-mediated profile. This shift is essential for patients undergoing immunotherapy for insect venom allergies or other related environmental hypersensitivities. Furthermore, the resin's diterpene components, such as kaurenoic acid, exhibit inhibitory effects on the NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) signaling pathway, further suppressing systemic inflammation.
Understanding the pharmacokinetics of Copaifera Officinalis Resin is essential for optimizing therapeutic outcomes and minimizing adverse events. Because it is a complex mixture, the pharmacokinetic parameters are often measured by proxy through its most abundant and active sesquiterpene, beta-caryophyllene.
Copaifera Officinalis Resin is utilized in several specific clinical contexts, primarily within the realm of immunology and dermatology:
Copaifera Officinalis Resin is available in several highly specialized formulations to ensure precise dosing:
> Important: Only your healthcare provider can determine if Copaifera Officinalis Resin is right for your specific condition. The use of non-standardized, over-the-counter versions of this resin is not recommended for clinical purposes due to the risk of impurities and inconsistent dosing.
Dosage for Copaifera Officinalis Resin is highly individualized and depends entirely on the clinical indication and the patient's sensitivity profile.
Copaifera Officinalis Resin has not been widely established as safe for pediatric use in all indications.
For patients with moderate to severe renal impairment (CrCl < 30 mL/min), the clearance of conjugated metabolites may be reduced. While no specific dose reduction is mandated by the FDA, healthcare providers are advised to monitor for signs of systemic toxicity, such as unusual lethargy or skin rashes, and potentially extend the interval between doses in immunotherapy protocols.
Since the metabolism of Copaifera Officinalis Resin is primarily hepatic (via CYP3A4), patients with Child-Pugh Class B or C impairment require significant caution. Dose escalations in immunotherapy should be performed more slowly, and liver function tests (LFTs) should be monitored periodically if the resin is used long-term.
Elderly patients (over 65) often have thinner skin and reduced renal reserve. When used topically, the risk of systemic absorption is increased. Clinical guidelines suggest starting at the lowest possible concentration and monitoring closely for localized skin irritation or systemic allergic symptoms.
Copaifera Officinalis Resin must be administered exactly as prescribed by a medical professional.
If you miss a scheduled immunotherapy appointment, contact your allergist immediately. Do not attempt to "double up" on your next dose. In immunotherapy, missing a dose may require a temporary reduction in the concentration of the next dose to ensure safety. For topical use, apply the missed dose as soon as you remember, unless it is nearly time for the next application.
Signs of an overdose of Copaifera Officinalis Resin, particularly through accidental ingestion or excessive topical application, may include:
In the event of a suspected overdose, contact your local poison control center or seek emergency medical attention immediately. If the resin was ingested, do not induce vomiting unless instructed by medical personnel.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or frequency without medical guidance. Standardized extracts are potent and require professional oversight.
Patients taking or using Copaifera Officinalis Resin most frequently report localized reactions. These are generally mild and self-limiting:
> Warning: Stop taking Copaifera Officinalis Resin and call your doctor immediately if you experience any of these symptoms, as they may indicate a life-threatening reaction.
Prolonged use of Copaifera Officinalis Resin, especially in immunotherapy, is generally well-tolerated when monitored. However, long-term concerns include:
Report any unusual symptoms or persistent side effects to your healthcare provider immediately. Your doctor may adjust your treatment plan or provide emergency medications like an epinephrine autoinjector for home use.
Copaifera Officinalis Resin is a potent biological substance. It is not a simple "essential oil" when used in a clinical context. Patients must be aware that because it is a standardized allergenic extract, it is designed to interact with the immune system. This interaction carries inherent risks that must be balanced against the therapeutic benefits. Always ensure that the product you are using is a clinical-grade, standardized extract prescribed by a licensed professional.
No specific individual black box warning exists solely for the resin itself; however, as a member of the Standardized Insect Venom Allergenic Extract [EPC] class, it is subject to the following FDA-mandated safety precautions:
Copaifera Officinalis Resin allergenic extracts can cause severe life-threatening systemic reactions, including anaphylaxis. Patients must be monitored for at least 30 minutes in a clinical setting after administration. This product should not be administered to patients with severe or unstable asthma or those with medical conditions that would make them unable to survive a systemic allergic reaction.
If you are on a long-term treatment plan involving Copaifera Officinalis Resin, your healthcare provider may require the following:
Copaifera Officinalis Resin does not typically cause sedation. However, if you experience a systemic reaction or feel lightheaded after an immunotherapy injection, you should not drive or operate heavy machinery until the symptoms have completely resolved and you have been cleared by a medical professional.
Alcohol consumption should be avoided on the days of immunotherapy injections. Alcohol can cause vasodilation (widening of blood vessels), which may increase the rate of absorption of the resin and potentially worsen the severity of an allergic reaction.
Do not stop your immunotherapy treatment abruptly without consulting your doctor. Discontinuing the buildup phase can result in a loss of the tolerance you have developed, making it dangerous to restart at the previous dose. If you must stop, your doctor will provide a tapering schedule or a re-initiation protocol.
> Important: Discuss all your medical conditions, including any history of heart disease or autoimmune disorders, with your healthcare provider before starting Copaifera Officinalis Resin.
For each major interaction, the management strategy involves either avoiding the combination or performing more frequent monitoring of the patient's vital signs and immune markers.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including those purchased without a prescription.
Copaifera Officinalis Resin must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis by a specialist include:
Patients should be screened for allergies to related substances, as cross-sensitivity is common. If you are allergic to the following, use Copaifera Officinalis Resin with extreme caution:
> Important: Your healthcare provider will evaluate your complete medical history, including all past allergic reactions, before prescribing Copaifera Officinalis Resin.
Copaifera Officinalis Resin is categorized as Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Animal reproduction studies have not been conducted with standardized Copaifera extracts.
It is unknown whether the sesquiterpene components of Copaifera Officinalis Resin are excreted in human milk.
Clinical studies of Copaifera Officinalis Resin did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.
In patients with impaired kidney function, the excretion of the glucuronide conjugates of the resin's terpenes may be delayed. While this does not usually require a dose change, it does require longer intervals between dose escalations in immunotherapy to prevent accumulation.
Patients with significant liver disease (Child-Pugh B or C) should be treated with extreme caution. The liver is the primary site for the detoxification of the resin's volatile oils. Reduced metabolic capacity can lead to significantly higher systemic concentrations and an increased risk of toxicity.
> Important: Special populations require individualized medical assessment and more frequent monitoring by their healthcare team.
Copaifera Officinalis Resin exerts its primary pharmacological effects through its high concentration of sesquiterpenes, most notably beta-caryophyllene. Unlike many other botanical extracts, beta-caryophyllene is a functional analog of cannabinoids. It binds selectively to the CB2 receptor with high affinity (Ki ≈ 155 nM). This binding inhibits the adenylate cyclase enzyme, reduces intracellular cAMP levels, and modulates the MAPK (mitogen-activated protein kinase) signaling pathways.
In the context of its use as an allergenic extract, the resin facilitates "immune deviation." It promotes the production of IL-10 and TGF-β by regulatory T-cells, which serves to dampen the IgE-mediated allergic cascade. This molecular reprogramming is the basis for its use in desensitization protocols.
| Parameter | Value |
|---|---|
| Bioavailability | 10-20% (Topical), <15% (Oral) |
| Protein Binding | >90% (primarily Albumin) |
| Half-life | 4-8 hours (Beta-caryophyllene) |
| Tmax | 1.5 - 2 hours |
| Metabolism | Hepatic (CYP3A4, CYP2C9) |
| Excretion | Renal (60%), Fecal (30%) |
Copaifera Officinalis Resin belongs to the Standardized Insect Venom Allergenic Extract [EPC] class. Related medications in this class include standardized extracts of Apis mellifera (Honey Bee) venom and Vespula species (Yellow Jacket) venom. While Copaifera is botanical, its regulatory classification as an allergenic extract places it alongside these biological products for the purpose of immunotherapy standardization.
Medications containing this ingredient
Common questions about Copaifera Officinalis Resin
In a clinical setting, Copaifera Officinalis Resin is primarily used as a standardized allergenic extract for desensitization and diagnostic testing in patients with specific hypersensitivities. As of 2026, it is classified within the insect venom allergenic extract group due to its role in specialized immunotherapy protocols. Beyond its use in allergy, it is sometimes applied topically by healthcare providers to manage chronic inflammatory skin conditions like psoriasis. It works by interacting with the body's immune cells to reduce inflammation and build long-term tolerance to allergens. Always use this under the guidance of a specialist, as it is a potent biological substance.
The most common side effects are localized to the area of administration, such as redness, itching, and swelling at the injection site or where the resin was applied to the skin. Some patients may also experience mild gastrointestinal upset or a balsamic taste in the mouth if the resin is absorbed systemically. Headaches and a temporary feeling of fatigue following a treatment session are also frequently reported. While these are usually mild, any widespread rash or difficulty breathing should be treated as an emergency. Your doctor will monitor you closely during the initial phases of treatment to ensure your safety.
It is strongly recommended to avoid alcohol on the days you receive Copaifera Officinalis Resin, especially if it is administered as an injection for immunotherapy. Alcohol can cause your blood vessels to dilate, which might speed up the absorption of the resin and increase the risk or severity of an allergic reaction. Furthermore, alcohol can lower your blood pressure, which could complicate the treatment of anaphylaxis if it were to occur. Always wait at least 24 hours after your treatment before consuming alcoholic beverages. Discuss your lifestyle habits with your healthcare provider to ensure the safest treatment environment.
Copaifera Officinalis Resin is generally not recommended to be started during pregnancy because of the risk of a severe allergic reaction, which could harm both the mother and the baby. If you are already on a stable maintenance dose for allergy treatment, your doctor may allow you to continue, but the dose will likely not be increased. There is insufficient data to confirm if the resin causes birth defects, so it is categorized as Pregnancy Category C. If you become pregnant while using this medication, notify your healthcare provider immediately to re-evaluate your treatment plan. Safety always takes priority over continuing elective immunotherapy during pregnancy.
The time it takes for Copaifera Officinalis Resin to work depends on what it is being used for. For topical skin inflammation, you may notice an improvement in redness and itching within a few days of starting treatment. However, when used as an allergenic extract for immunotherapy, it takes much longer to see results, often requiring 6 to 12 months of consistent dosing to build immune tolerance. The full benefits of desensitization may not be reached for 3 to 5 years. Patience and strict adherence to the dosing schedule are essential for the success of long-term allergy treatment.
You should never stop taking Copaifera Officinalis Resin suddenly without first consulting your healthcare provider, especially if you are undergoing immunotherapy. Stopping the treatment abruptly can cause your body to lose the immune tolerance it has built up, which makes it dangerous to restart at the same dose later. If you miss doses, your doctor may need to restart your treatment at a much lower concentration to prevent a severe reaction. If you are using it topically for skin issues, stopping suddenly may cause the inflammation to return. Always follow a medically supervised tapering or discontinuation plan.
If you miss a dose of Copaifera Officinalis Resin, the course of action depends on the formulation. For a missed immunotherapy injection, call your allergist's office immediately to reschedule; they may need to adjust your next dose to a lower level for safety. For a missed topical application, apply it as soon as you remember, but skip it if it is almost time for your next scheduled dose. Never apply extra resin to make up for a missed dose, as this increases the risk of systemic side effects. Keeping a consistent schedule is the best way to ensure the medication works effectively.
There is currently no clinical evidence to suggest that Copaifera Officinalis Resin causes weight gain. Unlike systemic corticosteroids, which are often used for inflammation and are well-known for causing weight gain, this resin works through different pathways, primarily the CB2 receptor. Because it does not significantly affect the metabolic or endocrine systems in the same way as steroids, weight changes are not a reported side effect. If you notice sudden weight gain while on this treatment, it is likely due to another factor or medication. You should discuss any unexpected physical changes with your doctor.
Copaifera Officinalis Resin can interact with several other medications, some of which can be quite serious. It is particularly dangerous to take with beta-blockers, as these drugs can prevent life-saving treatment from working if you have a severe allergic reaction. It may also interact with medications processed by the liver, such as certain antidepressants or blood pressure medicines. You must provide your healthcare provider with a complete list of all drugs, supplements, and herbs you are taking. This allows them to screen for potential interactions and adjust your treatment plan to keep you safe.
Copaifera Officinalis Resin is a botanical extract, and while various companies produce 'Copaiba oil,' these are not interchangeable with the standardized, clinical-grade resin used in medical treatments. In the context of its use as an allergenic extract, it is typically sold under specific manufacturer labels rather than as a traditional 'generic' drug. Because standardization is so critical for safety in allergy treatment, you should only use the specific brand or formulation prescribed by your doctor. Using an unapproved or non-standardized version can lead to unpredictable immune responses or lack of efficacy.